BERETTA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 13.319
AS - Asia 10.749
EU - Europa 6.138
SA - Sud America 1.402
AF - Africa 218
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 31.851
Nazione #
US - Stati Uniti d'America 12.567
SG - Singapore 3.751
VN - Vietnam 2.426
CN - Cina 1.857
IT - Italia 1.582
HK - Hong Kong 1.176
BR - Brasile 1.072
RU - Federazione Russa 1.037
DE - Germania 800
SE - Svezia 660
CA - Canada 608
IE - Irlanda 413
GB - Regno Unito 367
BD - Bangladesh 318
UA - Ucraina 291
FR - Francia 274
IN - India 260
FI - Finlandia 176
KR - Corea 152
TR - Turchia 129
AR - Argentina 128
ID - Indonesia 108
ES - Italia 93
IQ - Iraq 92
NL - Olanda 91
MX - Messico 86
AT - Austria 85
JP - Giappone 74
ZA - Sudafrica 67
PL - Polonia 56
PK - Pakistan 49
CO - Colombia 48
VE - Venezuela 45
PH - Filippine 44
SA - Arabia Saudita 43
UZ - Uzbekistan 42
EC - Ecuador 41
BE - Belgio 37
DK - Danimarca 31
EG - Egitto 31
LT - Lituania 28
MY - Malesia 24
CH - Svizzera 23
MA - Marocco 23
CZ - Repubblica Ceca 22
CL - Cile 21
KE - Kenya 21
TH - Thailandia 20
IR - Iran 19
AE - Emirati Arabi Uniti 16
JO - Giordania 16
PY - Paraguay 16
TN - Tunisia 14
NP - Nepal 13
PE - Perù 13
AZ - Azerbaigian 12
ET - Etiopia 12
OM - Oman 12
UY - Uruguay 12
CR - Costa Rica 11
DZ - Algeria 11
IL - Israele 11
JM - Giamaica 11
KG - Kirghizistan 11
LB - Libano 11
DO - Repubblica Dominicana 10
SN - Senegal 10
GR - Grecia 8
HU - Ungheria 8
MN - Mongolia 8
AL - Albania 7
BG - Bulgaria 7
AU - Australia 6
EU - Europa 6
GE - Georgia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BO - Bolivia 5
PA - Panama 5
RO - Romania 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
CI - Costa d'Avorio 4
EE - Estonia 4
HR - Croazia 4
KH - Cambogia 4
LV - Lettonia 4
MD - Moldavia 4
TG - Togo 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
GT - Guatemala 3
HN - Honduras 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MM - Myanmar 3
Totale 31.788
Città #
Singapore 1.841
Ann Arbor 1.382
Ashburn 1.362
Hong Kong 1.135
San Jose 962
Hanoi 691
Ho Chi Minh City 680
Chandler 644
Woodbridge 635
Fairfield 517
Houston 508
Milan 485
Frankfurt am Main 455
Toronto 436
Dublin 402
Los Angeles 365
Santa Clara 362
New York 357
Dallas 349
Jacksonville 303
Wilmington 280
Hefei 271
Beijing 246
Seattle 246
Chicago 222
The Dalles 218
Dearborn 216
Cambridge 199
Princeton 173
Seoul 143
Boardman 136
Buffalo 131
Hangzhou 123
Lauterbourg 122
Shanghai 115
Rome 114
São Paulo 109
Council Bluffs 107
Da Nang 101
Moscow 85
Nanjing 78
Helsinki 76
Altamura 74
Jakarta 73
Orem 73
Munich 70
Lawrence 68
Haiphong 65
Nuremberg 62
Tokyo 61
Montreal 56
Guangzhou 52
Dong Ket 51
Lachine 51
London 51
San Diego 51
Denver 50
Vienna 45
Columbus 44
Hải Dương 44
Warsaw 44
Biên Hòa 43
Baghdad 41
Quận Bình Thạnh 37
Brooklyn 36
Mountain View 36
Tashkent 36
Brussels 35
Can Tho 35
Rio de Janeiro 35
Shenyang 35
Atlanta 34
Poplar 34
Thái Nguyên 34
Quận Một 33
Manchester 31
Phoenix 31
Johannesburg 30
Nanchang 30
Dhaka 29
Fremont 29
San Francisco 29
Stockholm 29
Hebei 27
Mexico City 27
Vũng Tàu 27
Andover 26
Turku 26
Amsterdam 25
Ninh Bình 25
Istanbul 24
Boston 23
Bắc Giang 23
Turin 23
Ha Long 22
Salt Lake City 22
Zhengzhou 22
Ankara 21
Changsha 21
Chennai 21
Totale 19.614
Nome #
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 1.103
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 564
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 547
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 478
The role of clinical and neuroimaging features in the diagnosis of CADASIL 437
Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study 426
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 404
Guillain-Barré syndrome related to COVID-19 infection 395
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 391
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 391
Implementation of continuous qEEG in two neurointensive care units by intensivists: a feasibility study 382
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 378
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 368
Incidence and predictors of acute symptomatic seizures after stroke 362
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 360
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 357
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 357
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 355
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 353
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 352
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 344
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 322
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 319
Intracranial Collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 315
Topographical and morphological patterns of post reperfusion molecular penumbra 312
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 310
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment 309
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 308
Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG) 304
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 297
Therapeutic modulation of intracranial collateral flow improves outcome in experimental ischemic stroke 296
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 295
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review 294
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 291
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 291
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 290
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 290
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 288
Guillain–Barré Syndrome Associated with COVID-19 288
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection 286
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 282
Absence and reappearance of N20 response after thiopental withdrawal in postanoxic coma 279
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 272
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 272
Intracranial collateral flow in experimental ischemic stroke. From hemodynamic monitoring to collateral therapeutics 271
Thermal plantar test in experimental ischemic stroke 269
A multidisciplinary approach to screen the post-COVID-19 conditions 268
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 267
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 265
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 264
Experimental in-vivo model of intravascular shunting for neurosurgical bypass 263
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 261
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 261
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 259
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 256
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 255
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 254
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 252
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: The ICARO-2 study 248
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 245
The THRombolysis and STatins (THRaST) study 243
Cerebral collateral circulation in experimental ischemic stroke 242
Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion 239
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 234
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 232
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? 231
Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus 222
Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report 220
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW) 219
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 218
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 217
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 217
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 214
Discontinuation of antiseizure medications in seizure-free patients with long-term follow-up: Patients’ profile, seizure recurrence, and risk factors 214
Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study 212
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial 209
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 206
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 199
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients 199
Pharmacological manipulation of glutamate transport 197
Peripheral markers of glutamatergic dysfunction in neurological disease: focus on ex vivo tools 195
Brain ultrasound rehearsal before surgery: A pilot cadaver study 195
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 193
Head-down tilt 15° increases cerebral perfusion before recanalization in acute ischemic stroke. A pre-clinical MRI study 190
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 189
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 185
Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults 184
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 184
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 183
Elevated peripheral leukocyte counts in acute cervical artery dissection 183
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 182
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 181
Spectral properties of the EEG during recovery of consciousness after acute brain injury 180
Head down positioning before recanalization in acute ischemic stroke 180
Possible neuroprotective strategies in ALS 179
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate 178
Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training 178
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy) 173
Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database 171
Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke 171
Totale 28.110
Categoria #
all - tutte 99.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 0 0 159
2021/20221.378 129 137 155 87 106 98 52 54 77 111 146 226
2022/20232.259 257 710 202 224 118 328 24 138 132 10 64 52
2023/20241.818 46 38 95 115 198 393 362 52 176 18 63 262
2024/20256.822 266 487 239 203 440 266 348 201 533 840 846 2.153
2025/202614.172 1.750 956 1.047 1.392 1.639 684 1.995 583 971 1.241 876 1.038
Totale 32.549